What You Need to Know Before Starting Your Practice: A Focus on Diabetic Macular Edema

Supported by an educational grant from Regeneron Pharmaceuticals Inc.

This activity is jointly povided by



Treatment of patients with diabetic macular edema (DME) continues to evolve, with the emergence of new data and new diagnostic techniques. This leads to many questions for retina fellows contemplating the completion of their training and entering retina practice. This interactive, online, question-driven, video panel discussion between lead faculty and second-year retina fellows will provide participants with the opportunity to consider the efficacy and safety of available therapies, the use of emerging diagnostic techniques, and optimal treatment plans for patients.        

Target Audience

The educational design of this activity addresses the needs of retina fellows, practicing retina specialists, and comprehensive ophthalmologists involved in the treatment of patients with DME. No prerequisites required.

Learning Objectives

After completing this activity, the participant should be better able to:

  • DESCRIBE various principles of retina practice management.
  • EVALUATE the latest clinical data for the treatment of DME.
  • COMPARE the effect of dosing strategies on the efficacy and safety of current and emerging therapies for the management of DME.
Additional information

The goal of this activity is to provide retina fellows and practicing retina specialists with the most up-to-date clinical knowledge and strategies for the optimal treatment and management of patients with DME.

Accreditation Statement: 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and ASiM. Global is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement: 

Global Education Group designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

After reviewing this online activity, participants may receive credit by completing the CME test, evaluation, and receiving a score of 70% or higher.

Term of Offering

This activity was released on March 31, 2017 and is valid until June 30, 2018. Requests for credit must be made no later than June 30, 2018.

Copyright Information

All rights reserved. No part of this syllabus may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in articles or reviews.

Global Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Fee Information

There is no fee for this educational activity.

Confidentiality Disclaimer for CME Activity Participant: 

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit(s)™
Course opens: 
Course expires: 

Quan Dong Nguyen, MD, MSc (Co-Chair)
Omaha, Nebraska

Diana V. Do, MD (Co-Chair)
Omaha, Nebraska

Dean Eliot, MD
Massachusetts Eye and Ear
Harvard Medical School
Boston, Massachusetts

Judy E. Kim, MD
Professor of Ophthalmology
Vitreoretinal Diseases and Surgery
Medical College of Wisconsin
Milwaukee, Wisconsin

Srinivas R. Sadda, MD
President and CSO
Stephen J. Ryan – Arnold and Mabel Beckman Endowed Chair
Professor of Ophthalmology
Doheny Eye Institute
University of California
Los Angeles, California

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:


Name of Faculty or Presenter

Reported Financial Relationship

   Dean Eliot, MD

 Served as a consultant/independent contractor for: Alcon,    Alimera Sciences Inc, Allergan Inc, Dutch Ophthalmic USA, and Santen Pharmaceutical Co Ltd.

   Judy E. Kim, MD

Served as a consultant/independent contractor for: Bausch & Lomb Incorporated and Notal Vision Inc; and received grant/research support from: Carl Zeiss, Notal Vision Inc, and Optos.

   Srinivas R. Sadda, MD

Received grant/research support from and served as a consultant/independent contractor for: Allergan Inc, Carl Zeiss Meditec Inc, Genentech Inc, and Optos; and served as a consultant/independent contractor for Alcon, Bayer, Iconic Therapeutics, and Novartis.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and ASiM do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Note: The mention of a specific wide-field retinal imaging unit in this presentation is not an endorsement of this brand and is necessary in order to fulfill the educational objectives of this activity.  However, it is the only noncontact, widefield angiography system providing a 200 degree view currently available.

Available Credit

  • 0.50 AMA PRA Category 1 Credit(s)™

Accreditation Period

Course opens: 
Course expires: 
Please login or register to take this course.

Required Hardware/software

System Requirements

Microsoft Windows 2000 SE or above.
Flash Player Plugin (v7.0.1.9 or greater)
Internet Explorer (v5.5 or greater), or Firefox
Adobe Acrobat Reader*

MAC OS 10.2.8
Flash Player Plugin (v7.0.1.9 or greater)
Adobe Acrobat Reader*
Internet Explorer is not supported on the Macintosh.

*Required to view printable (PDF) version of the lesson.